BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34864404)

  • 1. Redox sensitive nano-capsules self-assembled from hyaluronic acid-hydroxychloroquine conjugates for CD44-targeted delivery of hydroxychloroquine to combat breast cancer metastasis in vitro and in vivo.
    He Y; Xu Y; Huang Y; Quang H; Xia X; Zhao H; Xiao Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2022 Feb; 210():112249. PubMed ID: 34864404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
    Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
    Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
    Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
    Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
    Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
    Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
    J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer.
    Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F
    Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
    Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
    Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
    Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
    ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
    Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q
    Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
    Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
    Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
    Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
    Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
    Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saporin-loaded CD44 and EGFR dual-targeted nanogels for potent inhibition of metastatic breast cancer in vivo.
    Chen J; He H; Deng C; Yin L; Zhong Z
    Int J Pharm; 2019 Apr; 560():57-64. PubMed ID: 30699364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Hyaluronic Acid-Decorated Redox-Responsive Magnetic Complex Micelle for Targeted Drug Delivery with Enhanced Antitumor Efficiency and Anti-Cell-Migration Activity.
    Sang M; Zhang Z; Liu F; Hu L; Li L; Chen L; Feng F; Liu W; Qu W
    J Biomed Nanotechnol; 2018 Mar; 14(3):477-495. PubMed ID: 29663921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin delivered by redox-responsive Hyaluronic Acid-Ibuprofen prodrug micelles for treatment of metastatic breast cancer.
    Chai Z; Teng C; Yang L; Ren L; Yuan Z; Xu S; Cheng M; Wang Y; Yan Z; Qin C; Han X; Yin L
    Carbohydr Polym; 2020 Oct; 245():116527. PubMed ID: 32718631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs.
    Liu J; Zhang D; Lian S; Zheng J; Li B; Li T; Jia L
    Int J Nanomedicine; 2018; 13():7457-7472. PubMed ID: 30532533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System.
    Yu T; Li Y; Gu X; Li Q
    Front Pharmacol; 2020; 11():532457. PubMed ID: 32982750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-Sensitive and Intrinsically Fluorescent Photoclick Hyaluronic Acid Nanogels for Traceable and Targeted Delivery of Cytochrome c to Breast Tumor in Mice.
    Li S; Zhang J; Deng C; Meng F; Yu L; Zhong Z
    ACS Appl Mater Interfaces; 2016 Aug; 8(33):21155-62. PubMed ID: 27509045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.